GH1 and neoplasm: Long-acting somatostatin analogs (SSA), the drugs generally used for this purpose, restore “safe” levels of GH and IGF-I in 50-75% of acromegalic patients and produce some degree of tumor shrinkage in 50–80% [3-5].